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Michael H. Gollob, MD,*† Calum J. Redpath, MBCHB, PHD,† Jason D. Roberts, MD*
Ottawa, Ontario, Canada
Objectives We aimed to develop diagnostic criteria for the short QT syndrome (SQTS) to facilitate clinical evaluation of sus-
pected cases.
Background The SQTS is a cardiac channelopathy associated with atrial fibrillation and sudden cardiac death. Ten years after
its original description, a consensus regarding an appropriate QT interval cutoff and specific diagnostic criteria
have yet to be established.
Methods The MEDLINE database was searched for all reported cases of SQTS in the English language, and all relevant
data were extracted. The distribution of QT intervals and electrocardiographic (ECG) features in affected cases
were analyzed and compared to data derived from ECG analysis from general population studies.
Results A total of 61 reported cases of SQTS were identified. Index events, including sudden cardiac death, aborted car-
diac arrest, syncope, and/or atrial fibrillation occurred in 35 of 61 (57.4%) cases. The cohort was predominantly
male (75.4%) and had a mean QTc value of 306.7 ms with values ranging from 248 to 381 ms in symptomatic
cases. In reference to the ECG characteristics of the general population, and in consideration of clinical presen-
tation, family history, and genetic findings, a highly sensitive diagnostic scoring system was developed.
Conclusions Based on a comprehensive review of 61 reported cases of the SQTS, formal diagnostic criteria have been pro-
posed that will facilitate diagnostic evaluation in suspected cases of SQTS. Diagnostic criteria may lead to a
greater recognition of this condition and provoke screening of at-risk family members. (J Am Coll Cardiol
2011;57:802–12) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.09.048The short QT syndrome (SQTS) is a cardiac channelopathy
associated with a predisposition to atrial fibrillation and
sudden cardiac death. The arrhythmogenic potential of a
short QT interval was first suggested by Gussak et al. (1) in
2000 when they reported an isolated case of sudden cardiac
death in a young female, and the presence of early onset
atrial fibrillation in a separate family. Cardiac workup in
both instances revealed structurally normal hearts; however,
electrocardiography (ECG) was notable for markedly ab-
breviated QT intervals ranging from 260 to 280 ms (Bazett
corrected QT interval [QTc] values ranging from 248 to 300
ms) in affected subjects. Similar findings were reported a few
years later in a detailed description of 2 additional unrelated
families with short QT intervals who suffered from a high
incidence of sudden cardiac death in the absence of struc-
tural heart disease (2). These initial reports led to the
recognition of SQTS as a distinct clinical entity and have
From the *Inherited Arrhythmia Clinic and Arrhythmia Research Laboratory,
University of Ottawa Heart Institute, Ottawa, Ontario, Canada; and the †Arrhythmia
Service, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. The authors
have reported that they have no relationships to disclose.Manuscript received May 31, 2010; revised manuscript received August 20, 2010,
accepted September 27, 2010.been followed by numerous additional case descriptions
within the past decade that have furthered our insight into
this condition. To date, 3 separate genes encoding ion
channels involved in the cardiomyocyte action potential
have been implicated in the pathogenesis of SQTS, and
further genetic culprits are suspected (3–5). The diagnostic
hallmark of the condition remains a short ECG QT
interval; however, consensus on an appropriate cutoff value
and diagnostic criteria sufficient to establish a diagnosis of
SQTS have yet to emerge in the literature.
The diagnosis of SQTS is further complicated by the
presence of an overlapping range of QT intervals between
affected cases and apparently healthy subjects. This concept
is highlighted in a long-term follow-up study of healthy
Finnish individuals with short (340 ms) and very short
(320 ms) QTc values who had no documented arrhythmic
events after an average follow-up of 29 years (6). Additional
studies examining subjects with short QT intervals from the
general population have revealed similarly benign outcomes
with no evidence of increased arrhythmic risk (7–9). These
findings suggest that the presence of a short QT interval in
isolation is not always predictive of an increased arrhythmic
risk and therefore should not invariably lead to a diagnosis
of SQTS.
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February 15, 2011:802–12 Short QT SyndromeThe prevalence and distribution pattern of short QT
intervals in the general population have been examined in an
effort to clarify the definition of a short QT interval. In a
middle-aged Finnish population involving 10,822 men and
women, 97.5% of males had a QTc value greater than 348 ms,
whereas a value of 364 ms was identified for females (6). Other
large studies involving American, Japanese, and Swiss subjects
have produced similar findings, with the mean QTc value
generally in the range of 400 to 410 ms, and values 2 standard
deviations below the mean approximating 350 ms in males and
365 ms in females (7,10,11).
In the congenital long-QT syndrome (LQTS), the pres-
ence of an overlapping range of QT intervals in affected
individuals and the general population is well recognized
(12). To overcome the diagnostic limitations associated with
relying on a single ECG parameter in LQTS, a scoring
system involving multiple clinical and ECG features was
developed (13,14). Recognition of an analogous scenario in
SQTS emphasizes the need for a similar approach. Accord-
ingly, we systematically reviewed the literature for reported
cases of SQTS in an effort to develop diagnostic criteria
designed to facilitate accurate clinical recognition of the
disorder.
Methods
The MEDLINE electronic database was searched for rele-
vant articles in the English language published before May
2010 using the medical subject heading or text word “short
QT.” Articles identified using this search strategy were
individually reviewed for the presence of reported cases of
SQTS. Published cases were considered eligible for inclu-
sion in the study if the report provided details regarding the
age, sex, clinical history, and QT interval of the affected
patient. In order to limit the study to cases of isolated
SQTS, subjects with structural heart disease and other
cardiac manifestations including complete heart block were
excluded. Clinical cases describing a coved-shape ST-
segment elevation pattern in leads V1 and V2, and associated
with abbreviated QT intervals and genetic mutations within
CACNA1c or CACNB2b, were not included in the analysis
15). These cases have a recognizable ECG pattern consis-
ent with the Brugada syndrome (15), and consideration of
n additional diagnosis of SQTS is of limited clinical value.
The following clinical variables were extracted, when
vailable, from each reported SQTS case: age at clinical
resentation; sex; QT interval; QTc value; the causative
ene and specific mutation; clinical history of sudden
ardiac death, aborted cardiac arrest, syncope, or atrial
brillation; and family history of SQTS or sudden cardiac
eath. When multiple QT intervals were reported for a
atient, the overall range was recorded and the shortest QT
nterval was used for analysis. A patient was defined as
ymptomatic following an episode of sudden cardiac death,
borted cardiac arrest, syncope, or atrial fibrillation.Use of QT/predicted QT in-
erval (QTp) for heart rate cor-
rection was included given the
poor performance of the QTc
value at extremes of heart rate
(16). The QTp was calculated
sing the formula developed by
autaharju et al. (17): [QTp 
656/(1  heart rate/100)]. Di-
viding the measured QT interval
by the QTp results in a percentage
predicted QT interval referred
to as the QT index; a QT index
value less than 88% is consid-
ered 2 standard deviations be-
low the mean (17).
When 12-lead surface ECGs were provided, the interval
extending from the J-point to the peak of the T-wave
(Jpoint-Tpeak) was measured. The J-point was taken as the
point of inflection between the S-wave and the ST-
segment, whereas the peak of the T-wave corresponded to
the highest point of the waveform. The Jpoint-Tpeak
interval was measured using the precordial lead with the
largest amplitude T-wave.
Categorical variables were analyzed as percentages,
whereas mean  SD and median (interquartile range [IQR])
values were calculated from continuous variables.
Results
The search strategy yielded 197 articles that were reviewed
for reported cases of SQTS. A total of 15 articles described
unique cases of SQTS with inclusion of relevant clinical
details. From these articles, 61 separate SQTS cases were
reviewed. A subset of patients were reported in multiple
articles; however, care was taken to ensure that these
subjects were only included once in the study. A detailed
listing of the clinical, electrocardiographic, and genetic
details of the 61 evaluated cases is provided in Table 1.
Clinical features. A total of 46 (75.4%) patients from the
overall cohort were male (Table 2). The presence of symp-
toms associated with SQTS, including sudden cardiac
death, aborted cardiac arrest, syncope, and atrial fibrillation,
occurred in 35 of the 61 (57.4%) subjects. There were 5
cases of sudden cardiac death and 15 of aborted cardiac
arrest, whereas an isolated, unexplained syncopal event
occurred in an additional 9 subjects. Atrial fibrillation was
experienced in 18.0% (11 of 61) of cases within the cohort.
Analysis on the basis of sex revealed that 8 of the 15 (53.3%)
females had experienced symptoms in comparison with 27
of the 46 (58.7%) males.
Amongst the 35 symptomatic patients, the age at clinical
presentation was available in 28 separate subjects. The
overall median age at clinical presentation was 21 years
(IQR: 17 to 31.8 years) with a value of 20 years (IQR: 17 to
Abbreviations
and Acronyms
ECG  electrocardiographic/
electrocardiogram
IQR  interquartile range
IVF  idiopathic ventricular
fibrillation
LQTS  long QT syndrome
QTc  Bazett corrected QT
interval
QTp  predicted QT interval
SQTS  short QT syndrome
VT  ventricular
tachycardia29 years) in males and 30 years (IQR: 19 to 44 years) in
Clinical and Genetic Features of the Reported Cases of SQTSTable 1 Clinical and Genetic Features of the Reported Cases of SQTS
SQTS Case #
(Ref. #) Family Presentation Gender QT (ms) QTc (ms) QT/QTp (%) Jp-Tp (ms) Gene Mutation SCD ACA Syncope AF Other
Family
History
1 (1,18) 1 17 yrs Female 225 (225–280) 300 71 100 KCNH2 N558K Absent Absent Absent Present SQTS
2 (1,18) 1 51 yrs Female 230 (230–260) 289 69 110 KCNH2 N558K Absent Absent Absent Present SQTS
3 (1,18) 1 21 yrs Male 240 (240–272) 267 66 90 KCNH2 N558K Absent Absent Absent Present SQTS
4 (1) 2 37 yrs Female 266 248 62 85 Not screened — Present — — Absent Negative
5 (2,3,19) 3 Not reported Female 270 295 71 120 KCNH2 N558K Absent Absent Absent Present Palpitations SQTS
6 (2,3,19) 3 8 months Male 260 300 71 70 KCNH2 N558K Absent Absent Present Absent SQTS
7 (2,3,19) 3 Asymptomatic Female 240 268 64 100 KCNH2 N558K Absent Absent Absent Absent SQTS
8 (2,3,19) 3 62 yrs Female 210 250 59 110 KCNH2 N558K Present — — Present SQTS
9 (2,3,19) 4 18 yrs Male 240 (240–270) 280 68 90 KCNH2 N558K Absent Absent Present Present SQTS
10 (2,3,19) 4 Asymptomatic Female 220 (220–250) 299 71 100 KCNH2 N558K Absent Absent Vasovagal Absent Palpitations SQTS
11 (2,3,19) 4 8 months Male 240 (240–260) 290 70 120 KCNH2 N558K Absent Present — Absent SQTS
12 (3) 5 51 yrs Male 294 288 73 95 Negative* — Absent Present — Absent SQTS
13 (3) 5 Asymptomatic Male Not reported 293 Unavailable Unavailable Negative* — Absent Absent Absent Absent SQTS
14 (4) 6 70 yrs Male 290 302 73 110 KCNQ1 V307L Absent Present — Absent Negative
15 (5) 7 Asymptomatic Female Not reported 315 Unavailable Unavailable KCNJ2 D172N Absent Absent Absent Absent SQTS
16 (5) 7 Asymptomatic Male Not reported 320 Unavailable Unavailable KCNJ2 D172N Absent Absent Absent Absent Presyncope SQTS
17 (19) 8 Asymptomatic Male 275 303 73 Unavailable Negative† — Absent Absent Absent Absent SQTS
18 (19) 8 29 yrs Male 290 311 75 110 Negative† — Absent Absent Present Absent SQTS
19 (19) 8 50 yrs Male 280 313 75 120 Negative† — Absent Absent Present Present SQTS
20 (19) 8 Asymptomatic Male 300 310 75 Unavailable Negative† — Absent Absent Absent Absent SQTS
21 (19,20,21) 9 Not reported Male 280 302 73 Unavailable Negative† — Absent Absent Absent Present SQTS
22 (19,20,21) 9 Asymptomatic Male 300 315 76 Unavailable Negative† — Absent Absent Absent Absent PMVT on ETT SQTS
23 (19,20,21) 9 18 yrs Male 270 308 73 110 Negative† — Absent Present — Absent SQTS
24 (19) 10 Asymptomatic Female 320 317 78 Unavailable Negative† — Absent Absent Absent Absent SQTS
25 (19) 10 14 yrs Male 240 282 67 Unavailable Negative† — Absent Absent Present Absent SQTS
26 (19) 10 Asymptomatic Female 300 333 80 Unavailable Negative** — Absent Absent Absent Absent SQTS
27 (19) 11 Asymptomatic Male 290 338 80 Unavailable Negative† — Absent Absent Absent Absent SQTS
28 (19) 11 17 yrs Male 210 291 69 Unavailable Negative† — Absent Present — Absent SQTS
29 (19) 12 16 yrs Male 280 317 76 Unavailable Negative† — Absent Present — Absent SQTS
30(19) 12 Asymptomatic Male 294 324 78 Unavailable Negative† — Absent Absent Absent Absent SQTS
31 (19) 12 Asymptomatic Male 320 333 80 Unavailable Negative† — Absent Absent Absent Absent SQTS
32 (19) 13 Asymptomatic Female 310 327 79 Unavailable Ongoing at report — Absent Absent Absent Absent SQTS
33 (19) 13 30 yrs Male 315 302 74 Unavailable Ongoing at report — Present — — Absent SQTS
34 (19) 13 Asymptomatic Male 315 323 78 Unavailable Ongoing at report — Absent Absent Absent Absent SQTS
35 (19) 14 19 yrs Male 300 317 76 Unavailable Negative† — Absent Present — Absent SCD
Continued on next page
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ContinuedTable 1 Continued
SQTS Case #
(Ref. #) Family Presentation Gender QT (ms) QTc (ms) QT/QTp (%) Jp-Tp (ms) Gene Mutation SCD ACA Syncope AF Other
Family
History
36 (19) 15 4 months Female 210 307 73 80 Not screened — Absent Present — Absent SCD
37 (19,22,23) 16 62 yrs Male 240 294 70 80 Negative† — Absent Absent Present Present SCD
38 (19,23) 17 27 yrs Male 300 312 75 Unavailable Not screened — Present — — Present Unknown
39 (24) 18 18 yrs Male 280 310 74 110 Negative‡ — Present — — Absent SQTS
40 (24) 18 Asymptomatic Male 320 328 80 160 Negative‡ — Absent Absent Absent Absent SQTS
41 (24) 18 Asymptomatic Male 280 298 72 120 Negative‡ — Absent Absent Absent Absent SQTS
42 (24) 18 Asymptomatic Male 290 326 78 120 Negative‡ — Absent Absent Absent Absent SQTS
43 (25) 19 20 yrs Male 308 (308–340) 257 (257–302) 67 110 Ongoing at report — Absent Absent Absent Present Negative
44 (26) 20 30 yrs Female 270 292 70 110 Not screened — Absent Present — Absent Negative
45 (27) 21 24 yrs Male 313 308 75 170 Negative† — Absent Absent Present Inducible at EPS SCD
46 (28) 22 22 yrs Male 334 (334–376) 349 (349–381) 85 140 KCNH2 E50D Absent Present — Absent Negative
47 (29) 23 13 yrs Male 300 283 (283-319) 77 80 Negative‡ — Absent Present — Absent Negative
48 (29) 24 Not reported Male 248 252 61 Unavailable Not reported — Absent Present — Absent SQTS
49 (29) 25 Not reported Male 280 313 75 Unavailable Not reported — Absent Present — Absent SQTS
50 (29) 26 Not reported Male 320 320 78 Unavailable Not reported — Absent Absent Present Absent Negative
51 (29) 27 Not reported Male 300 312 75 Unavailable Not reported — Absent Absent Present Inducible at EPS Negative
52 (29) 28 Not reported Male 245 315 74 Unavailable Not reported — Absent Present — Inducible at EPS SQTS
53 (29) 29 Asymptomatic Male 295 310 75 Unavailable Not reported — Absent Absent Absent Absent SQTS
54 (29) 30 Asymptomatic Male 280 262 65 Unavailable Not reported — Absent Absent Absent Absent SQTS
55 (29) 30 Asymptomatic Male 295 335 80 Unavailable Not reported — Absent Absent Absent Inducible at EPS SQTS
56 (29) 30 Asymptomatic Male 300 355 84 Unavailable Not reported — Absent Absent Absent Inducible at EPS SQTS
57 (30) 31 21 yrs Female 280 315 75 90 Not screened — Absent Present — Absent Negative
58 (31) 32 Asymptomatic Male 276 298 72 110 Not screened — Absent Absent Absent Absent SCD
59 (32) 33 Asymptomatic Male 322 329 80 Unavailable KCNH2 R1135H Absent Absent Absent Absent NSVT on Holter
monitor
SQTS
60 (32) 33 Asymptomatic Male 345 377 90 Unavailable KCNH2 R1135H Absent Absent Absent Absent SQTS
61 (32) 33 Asymptomatic Female 401 379 93 Unavailable KCNH2 R1135H Absent Absent Absent Absent SQTS
Negative genotype: *Genes screened: KCNH2, KCNQ1, KCNJ2, KCNE1, SCN5A, KCNE2, KCNJ3, KCNJ6, KCNJ11, KCND3, KCND2, KCNA5, KCNIP2, KCHAP, KCNIP1, ABCC8, ANKB, CHRM1, CHRM4, and CHRM5. †Genes screened: KCNH2, KCNQ1, and KNCJ2. ‡Details not
provided.
ACA aborted cardiac arrest; AF atrial fibrillation; EPS electrophysiology study; ETT exercise treadmill test; Jp-Tp Jpoint-Tpeak interval; NSVT nonsustained ventricular tachycardia; PMVT polymorphic ventricular tachycardia; QTc Bazett corrected QT interval;
QTp  predicted QT-interval; SCD  sudden cardiac death; SQTS  short QT syndrome.
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Short QT Syndrome February 15, 2011:802–12females (Table 2). Although the majority of individuals
came to clinical attention during late adolescence and early
adulthood, there were notable exceptions, including cases
that presented during infancy and a male patient (Subject
#14; KCNQ1 V307L) who remained asymptomatic until 70
ears of age when he presented with an aborted cardiac
rrest (Table 1).
The remaining 26 subjects, all asymptomatic, had been
lassified as SQTS on the basis of gene carrier status or the
resence of a short QT interval in the context of a
rst-degree relative with a diagnosis of SQTS. Of the
ndividuals considered asymptomatic, 2 had reported expe-
iencing either palpitations or a pre-syncopal event (Subjects
10 and #16). These complaints were not considered
ufficient to be classified as symptomatic given their rela-
ively high prevalence in the general population and non-
pecific nature. An additional 2 patients were found to have
bnormal findings on clinical diagnostic testing, including
n episode of polymorphic ventricular tachycardia during
xercise treadmill testing (Subject #22) and a period of
onsustained ventricular tachycardia (not specified if poly-
orphic) observed on Holter monitoring at night (Subject
59; KCNH2 R1135H).
CG parameters. QT VALUES. Analysis of QT and QTc
values was performed using the shortest values recorded for
each individual patient; in many cases, significant variability
of QT values was observed when subjects underwent mul-
tiple ECGs (Table 1). Examples include Subject #43, a
20-year-old male from Turkey referred for evaluation of
new-onset atrial fibrillation, whose QTc values ranged from
257 to 302 ms. Similarly, variable QTc values extending
from 283 to 319 ms were noted in Subject #47, a 13-year-
old male who presented with an aborted cardiac arrest.
Finally, Subject #46 (KCNH2 E50D) was a 22-year-old
male reported by our group with an aborted cardiac arrest
Analysis of Age, Sex, and QT Interval CharacterTable 2 Analysis of Age, Sex, and QT Interv
Characteristics Over
Presentation (yrs) n 28
Mean  SD 27.1
Median (IQR) 21 (17–
Overall range 4 months
QT, ms n 58
Mean  SD 281.8
Median (IQR) 285 (261
Overall range 210–
QTc, ms n 61
Mean  SD 306.7
Median (IQR) 310 (293
Overall range 248–
QT/QTp, % n 58
Mean  SD 74.1
Median (IQR) 74.5 (7
Overall range 59–
Abbreviations as in Table 1.whose QTc values ranged from 349 to 381 ms. Interestingly,ubject #46 first presented with a QTc value (381 ms) that
would generally be considered within the normal range.
The mean, median, interquartile, and overall ranges for
the QT, QTc, and QT/QTp values were calculated for the
overall cohort and then re-evaluated on the basis of sex and
symptoms (Tables 2 and 3). The QT values for the entire
group extended from 210 to 401 ms when uncorrected for
heart rate, and ranged from 248 to 381 ms when adjusted
with the Bazett correction formula. The mean and median
QTc values of the overall cohort were 306.7  26.5 ms and
310 ms (IQR: 293 to 320 ms), respectively. The QT index
(QT/QTp) was below 88%, or 2 SDs below the mean, in all
ut 2 SQTS cases (17). QT parameters are summarized in
ables 2 and 3.
Examination of QT intervals on the basis of sex revealed
imilar values in both males and females. The QTc values in
ales had a mean of 308.1  24.3 ms and a median of 310
s (IQR: 295 to 320 ms) compared with a mean of 302.3
33.0 ms and median of 300 ms (IQR: 290.5 to 316 ms)
n females. Findings for both the uncorrected QT intervals
nd QT/QTp values based on sex are shown in Table 2.
When analysis was restricted to subjects classified as
ymptomatic, the mean and median QTc values were 296.9
 22.1 ms and 302 ms (IQR: 288.5 to 312 ms). In
comparison, the QTc values tended to be longer in asymp-
omatic subjects, with a mean of 319.8  26.7 ms and
edian of 321.5 ms (IQR: 304.8 to 332 ms). The longest
ecorded QTc value (381 ms) in a symptomatic patient
belonged to a 22-year-old male who presented with an
aborted cardiac arrest (Subject #46; KCNH2 E50D),
whereas an asymptomatic gene carrier of the KCNH2
R1135H mutation (Subject #61) was responsible for the
longest QTc (379 ms) in asymptomatic subjects. Table 3
ontains results for the uncorrected QT and the QT/ QTp
of the SQTS Cohortaracteristics of the SQTS Cohort
Male Female
21 7
25.7 18.1 31.2 21.0
20 (17–29) 30 (19–44)
rs 8 months to 70 yrs 4 months to 62 yrs
44 14
286.2 29.0 268 52.9
) 290 (275.8–300) 268 (226.3–295)
210–345 210–401
46 15
308.1 24.3 302.3 33.0
310 (295–320) 300 (290.5–316)
252–381 248–379
44 14
74.6 5.4 72.5 8.5
75 (72–78) 71 (69.3–77.3)
61–90 59–93isticsal Ch
all
18.6
31.8)
to 70 y
36.5
.5–300
401
26.5
–320)
381
6.3
1–78)
93values for symptomatic and asymptomatic SQTS patients.
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February 15, 2011:802–12 Short QT SyndromeFinally, although the numbers were relatively low, the
QTc values associated with the 3 reported KCNH2 missense
utations were examined. The calculated mean and median
f the 10 reported cases of SQTS secondary to the KCNH2
588K mutation were 283.8  17.1 ms and 289.5 ms
IQR: 271 to 298 ms), respectively. In contrast, the single
ase of SQTS associated with the KCNH2 E50D mutation
Subject #46) had QTc values that ranged between 349 and
81 ms, whereas the QTc values associated with the
1135H KCNH2 mutation ranged from 329 to 379 ms
(Subjects #59 to #61). The single case containing the
KCNQ1 V307L mutation (Subject #14) had a QTc value of
02 ms, whereas the 2 members of the family carrying the
CNJ2 D172N mutation had QTc values of 315 ms
Subject #15) and 320 ms (Subject #16).
point-Tpeak. Measurement of the Jpoint-Tpeak interval
hen the 12-lead ECG accompanied the report was possi-
le in 30 separate cases. The mean Jpoint-Tpeak interval
as 107.6 22.3 ms with values that ranged from 70 to 170
s (Table 4). The 20 male subjects had a mean Jpoint-
peak interval of 111.3 25.6 ms, whereas the correspond-
ng mean value for the 10 female cases was 100.5 12.6 ms.
hen analyzed on the basis of symptoms, the mean
point-Tpeak interval of the 24 symptomatic subjects was
04.8  22.0 ms, in comparison with a value of 118.3 
2.3 ms in the 6 asymptomatic cases.
QT INTERVAL RESPONSE TO EXERCISE. The normal physi-
logic response of the QT interval to an increasing heart
ate is to shorten and can be evaluated using the QT/heart
ate (QT/HR) ratio during accelerating heart rate (33). In
QT Interval Parameters in Symptomatic and AsyTable 3 QT Interval Para eters in Symptom
Characteristics
QT, ms n
Mean  SD
Median (IQR)
Overall range
QTc, ms n
Mean  SD
Median (IQR)
Overall range
QT/QTp, % n
Mean  SD
Median (IQR)
Overall range
Abbreviations as in Table 1.
Analysis of the Jpoint-Tpeak Interval in SQTS CaTable 4 Analysis of the Jpoint-Tpeak Interva
Characteristics
Jp-Tp, ms
Overall
(n  30)
Male
(n  20)
Mean  SD 107.6 22.3 111.3 25.6
Median (IQR) 110 (90–120) 110 (92.5–120)
Overall range 70–170 70–170Abbrevations as in Table 1.ormal individuals, the QT/HR ratio generally exhibits a
inear relationship in response to exercise, and slopes have
een shown to typically range from 1.20 to 1.50
s/beats/min (33). The driving force of the measured slope
eflects the progressive shortening of the QT interval
elative to increasing heart rate. The presence of a markedly
lunted slope of the QT/HR relationship during exercise
as observed in 4 cases of SQTS with QT/HR slopes in the
ange of 0.22 to 0.59 ms/beats/min (28,34). This
nding suggests a lesser degree of QT shortening response
ith accelerating heart rate, possibly reflecting a lack of
epolarization reserve due to already enhanced repolarizing
urrents in the setting of SQTS.
enetics and family history. The presence of a positive
amily history for either SQTS or sudden cardiac death was
eported in 23 of 32 index cases (71.9%) (family history
ould not be verified in 1 index case). Review of the genetics
nderlying the SQTS cohort revealed that 7 of 33 index
ases had been found to possess a gain-of-function mutation
n 1 of the 3 known culprit voltage-gated potassium channel
enes: KCNH2, KCNQ1, and KCNJ2 (Table 5, Fig. 1). A
otal of 14 patients within 5 different families have been
ound to have a mutation in KCNH2. The KCNH2 N588K
utation was found in 3 of these families and until recently
ad been the only known KCNH2 causative mutation
3,18). In 2009, our group reported an E50D mutant in
ubject #46 (28), whereas the R1135H mutant was identi-
ed in a Japanese family (Subjects #59 to #61) (32).
The remaining 2 genes implicated in SQTS have, to date,
nly been identified in single index cases. The V307L
CNQ1 mutation was found in an apparently sporadic case
matic SQTS Casesand Asymptomatic SQTS Cases
Symptomatic Asymptomatic
35 23
270.2 33.3 299.5 34.7
280 (240–297) 300 (285–317.5)
210–334 240–401
35 26
296.9 22.1 319.8 26.7
302 (288.5–312) 321.5 (304.8–332)
248–381 262–379
35 23
71.9 5.0 77.4 6.6
73 (69.5–75) 78 (74–80)
59–85 64–93
QTS Cases
Female
(n  10)
Symptomatic
(n  24)
Asymptomatic
(n  6)
00.5 12.6 104.8 22.0 118.3 22.3
00 (92.5–110) 110 (90–110) 115 (102.5–120)
80–120 70–170 100–160mptoaticsesl in S
1
1
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Short QT Syndrome February 15, 2011:802–12of SQTS in a 70-year-old man (Subject #14) who suffered
a cardiac arrest in the absence of structural heart disease (4).
Following resuscitation, clinical evaluation was unremark-
able aside from a QTc of 302 ms on ECG. In contrast, the
172N KCNJ2 mutation has not been reported to have
been associated with adverse clinical events. It was identified
in a single family following referral of a 5-year-old girl
(Subject #15) for evaluation due to a short QTc value (315
ms) (5). The ECG of the 35-year-old father (Subject #16)
was also notable for a short QT interval (320 ms) and,
although he had not experienced any definitive clinical
events, he did report symptoms of palpitations and pre-
syncope since the age of 15.
Of the remaining 26 index cases, 9 had no mutations
identified in KCNH2, KCNQ1, and KCNJ2, indicating that
The Genetic Subtypes of SQTS andFrequ cy of Culprit Genetic MutationsTable 5 The Genetic ubtypes of SQTS andFrequency of Culprit Genetic Mutations
SQTS Subtype Culprit Gene
Reported
Mutation(s)
Number of Cases
(Families)
SQT1 KCNH2 N558K 10 (3)
E50D 1 (1)
R1135H 3 (1)
SQT2 KCNQ1 V307L 1 (1)
V141M* 1 (1)
SQT3 KCNJ2 D172N 2 (1)
Genotype unknown — — 44 (26)
*V141M was identified in a case of reported short QT syndrome (SQTS) identified in utero in
association with complete heart block; the patient was not included in our cohort due to the
additional presence of complete heart block (35).
Figure 1 Cellular Mechanism of Short QT Interval
A gain-of-function potassium channel mutation results in an increased efflux of po
tion and a shortened action potential duration. Additional cellular mechanisms, po
authors with the assistance of Craig Skaggs. PVC  premature ventricular contracother genetic culprits remain to be identified. Two index
cases were reported as genotype negative; however, the
specific genes screened were not cited. Genetic testing was
ongoing in 2 further index cases, 6 other index cases were
reportedly not screened, and it was unclear whether genetic
testing had been performed in the remaining 7.
Discussion
The SQTS is characterized by a short QT interval on ECG;
however, there remains a lack of consensus regarding an
appropriate QT interval cutoff warranting diagnostic con-
sideration. Furthermore, the existence of a range of QTc
values that overlap between reported cases of SQTS and the
general population complicates clinical assessment. In the
case of LQTS, a formalized diagnostic scoring system was
developed in an effort to facilitate evaluation of suspected
cases (13,14). Following a systematic review of all cases of
SQTS reported in the literature, we have developed a
similar diagnostic approach for SQTS (Table 6).
The SQTS diagnostic criteria have been divided into 4
different components including ECG, clinical history, fam-
ily history, and genotype. In order to be eligible to receive
points in the latter 3 sections, a minimum of 1 point must
be received from the ECG criteria. An overall score of 4
points or greater indicates a high-probability diagnosis of
SQTS, whereas 2 points or less makes a diagnosis of SQTS
low probability. Patients with a score of 3 points are
considered to have an intermediate probability of having
SQTS. Given the significant QT interval variation docu-
current from the cell resulting in an acceleration of cardiomyocyte repolariza-
due to nonpotassium channels, remain to be elucidated. Illustration designed by
F  ventricular fibrillation.tassium
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February 15, 2011:802–12 Short QT Syndromemented in individual patients from our cohort, continued
medical surveillance and serial electrocardiographic moni-
toring may serve to clarify the diagnosis in patients with
intermediate probability. This approach, coupled with ob-
taining ECGs from first-degree relatives, has previously
proven helpful in the context of the LQTS (36).
ECG criteria. The ECG component of the diagnostic
criteria relies on the Bazett correction formula (QTc) to
account for changes in the QT interval associated with heart
rate (37). Although this formula has important limitations
during bradycardia and tachycardia (16), it remains the most
commonly used heart rate correction factor in clinical
practice. Our definition of a short corrected QT interval
relied in part on data from large epidemiologic studies that
reported the distribution of corrected QT intervals in the
general population (6,7,10,11). These studies suggested that
a QTc value of approximately 350 ms in males and 365 ms
n females corresponded to values 2 standard deviations
elow the mean (6,7,10,11). In over 90% of SQTS cases,
oth the measured QTc value and QT index demonstrated
alues well below 2 SDs from the mean (QTc 350 ms and
T index 88%) of healthy subjects (Table 1). The mean
Tc value for our SQTS cohort was substantially lower at
06.7 26.5 ms with a relatively narrow IQR that stretched
from 293 to 320 ms. However, despite the apparent contrast
between QTc values in SQTS and the general population,
he standard deviation in SQTS cases was broad, and
xceptional cases were observed. The longest QTc value in
SQTS Diagnostic CriteriaTable 6 SQTS Diagnostic Criteria
Points
QTc, ms
370 1
350 2
330 3
Jpoint-Tpeak interval 120 ms 1
Clinical history*
History of sudden cardiac arrest 2
Documented polymorphic VT or VF 2
Unexplained syncope 1
Atrial fibrillation 1
Family history*
First- or second-degree relative with high-probability SQTS 2
First- or second-degree relative with autopsy-negative
sudden cardiac death
1
Sudden infant death syndrome 1
Genotype*
Genotype positive 2
Mutation of undetermined significance in a culprit gene 1
High-probability SQTS: 4 points, intermediate-probability SQTS: 3 points, low-probability SQTS:
2 points. Electrocardiogram: must be recorded in the absence of modifiers known to shorten the
QT. Jpoint-Tpeak interval must be measured in the precordial lead with the greatest amplitude
T-wave. Clinical history: events must occur in the absence of an identifiable etiology, including
structural heart disease. Points can only be received for 1 of cardiac arrest, documented
polymorphic VT, or unexplained syncope. Family history: points can only be received once in this
section. *A minimum of 1 point must be obtained in the electrocardiographic section in order to
obtain additional points.
VF  ventricular fibrillation; VT  ventricular tachycardia; other abbreviations as in Table 1.he SQTS cohort was observed in a 22-year-old male Subject #46) who presented with an aborted cardiac arrest.
is initial QTc value was 381 ms, and lowest subsequent
QTc was 349 ms. This patient was identified to have a
novel E50D missense mutation in the KCNH2 gene (28).
The range of short QTc intervals that may be associated
ith event risk is further highlighted in a reported series of
atients with “idiopathic ventricular fibrillation” (IVF), who
ere noted to have a mean QTc value of 371 ms, signifi-
cantly below the QTc value of healthy, sex- and age-
matched controls (38). Although speculative, these findings
suggest that a proportion of patients previously classified as
IVF may actually suffer from a pathology consistent with the
SQTS. Diagnostic consideration of SQTS in such patients
and subsequent screening of culprit genes may prove bene-
ficial. In light of the range of QTc intervals in documented
ases of SQTS and in previously diagnosed IVF cases, we
ave chosen a QTc value of 370 ms as an initial cutoff for
iagnostic consideration of this condition. Although a QTc
upper limit of 370 ms will include a proportion of normal
individuals, the diagnostic criteria require an association
with multiple different clinical or genetic details in order to
avoid an inappropriate diagnosis on the basis of QTc value
lone.
Individuals with a recorded QTc value of less than 370 ms
eceive a minimum of 1 point from the scoring system.
lthough QT duration has been observed to be greater in
emales, a phenomenon also observed at the lower limit of
ormal QT values, we have not chosen a separate cutoff
alue for females in view of similar QTc values being
observed in diagnosed males and females (Table 2) (6,7,10).
Additional points are assigned for increasingly abbreviated
QTc intervals, based on observations suggesting that very
short QT intervals are exceedingly rare in the general
population. In the large Finnish population study, a QTc
value 340 ms was observed in 0.4% of the population,
whereas a QTc value 320 ms was found in just 0.1% (6).
his low frequency of extremely short QT intervals was
urther corroborated by multiple additional studies that
emonstrated similar findings (7–9,11,39). Accordingly,
atients with a QTc value less than 350 ms receive 2 points,
hereas 3 points are assigned for a QTc value 330 ms. Of
ote, patients should not receive points in the presence of
odifiable factors known to abbreviate the QT interval such
s hypercalcemia, digoxin administration, and androgen use
40–42).
In addition to the QT interval, other distinctive features
ssociated with the ECGs of SQTS patients have been
eported, including the relative absence of an ST-segment.
ata suggest that extreme abbreviation of the Jpoint-Tpeak
nterval may help distinguish patients with the SQTS from
ealthy subjects with an apparent abbreviation of the ST-
egment and shortened QT intervals. Reported analyses of
0 symptomatic SQTS patients indicated a markedly short-
ned mean Jpoint-Tpeak interval (101 ms, range 80 to 120
s) in comparison with 12 healthy subjects with QTc values
320 ms (184 ms, range 150 to 240 ms) who had remained
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Short QT Syndrome February 15, 2011:802–12arrhythmia-free over an average follow-up of 29 years (43).
A separate ECG study involving 500 healthy subjects
identified mean Jpoint-Tpeak values of 188  11 ms and
14  15 ms in males and females, respectively (44). These
ndings suggest that a shortened Jpoint-Tpeak interval may
ermit ECG discrimination between individuals with a
athologic substrate consistent with the SQTS and those
ndividuals who possess a benign form of abbreviated QT
ntervals. Measurement of the Jpoint-Tpeak interval in 30
QTS cases from our cohort using the precordial lead with
he greatest T-wave amplitude, consistent with the previous
tudies, identified a mean value of 107.6  22.3 ms,
roviding further support for the presence of a markedly
bbreviated Jpoint-Tpeak interval in SQTS cases (Table 5).
rom these findings, the presence of a Jpoint-Tpeak interval
120 ms in the precordial lead with the greatest T-wave
mplitude is allocated 1 point. The cutoff of 120 ms
rovides high specificity for the SQTS based on current data
hile remaining readily recognizable on visual ECG inspec-
ion in clinical practice.
The presence of high-amplitude, peaked T waves, which
re frequently observed on ECG in SQTS subjects, was
onsidered for inclusion in the diagnostic scorecard. How-
ver, in contrast to measures of Jpoint-Tpeak, high-
mplitude T waves have not been shown to distinguish
QTS patients from healthy individuals with short QT
ntervals and no clinical events (43). Another morphological
-wave feature, the total cosine of the angle between the
ain vectors of the QRS and T-wave loops, has also been
eported to be abnormal in SQTS patients (45). However,
his parameter requires specific software for analysis, is not
sed routinely in clinical practice, and was not considered
ractical for use in diagnostic criteria. Finally, a high
revalence of early repolarization has been observed in
QTS patients; however, this observation in the diagnosis
f SQTS is limited, given its high frequency in the general
opulation (46).
The QT response to exercise was also considered for use
n the diagnostic critieria. At present, analysis of QT
esponse to accelerating heart rate has only been formally
eported in 4 cases of diagnosed SQTS (28,34). Analyses of
he QT/HR relation through exercise appears to demon-
trate a blunting of the slope with increasing heart rates.
owever, in the absence of validation of these observations
n a larger cohort of patients, and given the challenges of
easuring QT intervals during rapid heart rates, the diag-
ostic value of this test was deemed to be minimal and is not
ncluded in the diagnostic criteria.
linical history. Upon receiving a minimum of 1 point
rom the ECG section, cases are subsequently eligible to
eceive points from the other components of the SQTS
iagnostic criteria scorecard. Diagnostic points are provided
or a documented history of cardiac arrest (either aborted or
esulting in death), observed nonsustained polymorphic
entricular tachycardia (VT) or VF, unexplained syncope,
nd/or atrial fibrillation. Events must occur in the absence if other identified clinical pathologies. The events of a
ardiac arrest or nonsustained VT/VF result in 2 points,
hereas unexplained syncope and atrial fibrillation are only
ssigned a single point, given their relatively high prevalence
n the general population. Points can only be received for 1
f cardiac arrest, documented polymorphic VT, or unex-
lained syncope.
amily history and genotype. The final 2 components of
he diagnostic scoring system relate to heritability of the
yndrome. The importance of heritability is illustrated by
he finding that 23 of the 32 (71.9%) index cases reviewed
ad a family history of SQTS or sudden cardiac death. A
ositive family history for SQTS has been assigned 2 points
nd requires a high-probability diagnosis of SQTS (4 points
r greater) in a first- or second-degree relative. In contrast,
positive family history for sudden cardiac death with a
egative autopsy or sudden infant death syndrome in a first-
r second-degree relative in the absence of a high-
robability diagnosis of SQTS yields 1 point.
Genetic studies have implicated 5 separate genes in the
tiology of a proportion of patients with diagnosed SQTS,
lthough the majority of diagnosed cases do not have
eported genetic associations (3–5,15). The initial 3 genes
dentified were voltage-gated potassium channels whose
ain-of-function mutations accounted for the SQTS phe-
otype secondary to accelerated repolarization resulting
rom increased potassium efflux (Table 5, Fig. 1) (3–5). In
ontrast, the most recent genes reported are loss-of-function
utations in the CACNA1c and CACNB2b genes, which
ncode subunits of L-type calcium channels (15). However,
he 3 patients reported to harbor these mutations had clear
CG findings consistent with a Brugada type 1 pattern,
lbeit with abbreviated QT intervals. To most clinicians,
hese cases would be readily recognized as Brugada syn-
rome. Thus, in its purest form, the SQTS has 3 known
enetic culprits at the present time: KCNH2, KCNQ1, and
CNJ2. It is expected that further genes will be identified
nd novel cellular mechanisms of QT-interval shortening
lucidated.
The presence of a suspected disease-causing genetic
utation for the SQTS has been assigned a score of 2
oints. Identification of a novel mutation of undetermined
ignificance in a known gene associated with SQTS has
een assigned a single point. This is to acknowledge that the
nterpretation of genetic variations as disease causing may be
ncertain, especially in the context of novel genes that may
e identified in the future with little history in regard to
nown disease-causing variants or polymorphisms.
linical application of the SQTS diagnostic criteria
corecard. The proposed SQTS diagnostic criteria were
valuated using the 61 symptomatic and asymptomatic cases
hat were systematically reviewed from the literature. Of
hese cases, 58 of 61 (95%) would receive a diagnostic score
ndicating high-probability SQTS. Although the diagnostic
riteria provide a systematic diagnostic approach for SQTS
n suspected index cases, the value of the scorecard for
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February 15, 2011:802–12 Short QT Syndromeevaluation of family members is not expected to be highly
sensitive due to the common phenomena of incomplete
disease penetrance observed for inherited cardiac syn-
dromes. In addition, clinicians are encouraged to remain
cognizant of benign variants of QTc abbreviation, analo-
gous to the challenges of evaluating prolonged QT intervals
in consideration of LQTS. Treatment consideration should
be reserved for those cases receiving a high-probability
score, whereas medical surveillance or expert opinion con-
sidered for intermediate- or low-probability cases.
Conclusions
The absence of formalized diagnostic criteria for the SQTS
is associated with a lack of consensus regarding an appro-
priate QT interval cutoff suitable for diagnostic consider-
ation of this condition. This has been further complicated
by the recognition of an overlap of short QTc intervals in
reviously diagnosed cases and apparently healthy individ-
als from the general population. The proposed diagnostic
riteria will facilitate evaluation in suspected cases and may
ead to the reclassification of previously considered IVF
atients as having SQTS. A universal diagnostic approach
hould enhance recognition of SQTS patients and facilitate
linical evaluation of family members who may be at risk of
vents from this genetically-mediated arrhythmia syndrome.
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